BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22833499)

  • 1. The effects of zoledronic acid in the bone and vasculature support of hematopoietic stem cell niches.
    Soki FN; Li X; Berry J; Koh A; Sinder BP; Qian X; Kozloff KM; Taichman RS; McCauley LK
    J Cell Biochem; 2013 Jan; 114(1):67-78. PubMed ID: 22833499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
    Pozzi S; Vallet S; Mukherjee S; Cirstea D; Vaghela N; Santo L; Rosen E; Ikeda H; Okawa Y; Kiziltepe T; Schoonmaker J; Xie W; Hideshima T; Weller E; Bouxsein ML; Munshi NC; Anderson KC; Raje N
    Clin Cancer Res; 2009 Sep; 15(18):5829-39. PubMed ID: 19737962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid alters hematopoiesis and generates breast tumor-suppressive bone marrow cells.
    Ubellacker JM; Haider MT; DeCristo MJ; Allocca G; Brown NJ; Silver DP; Holen I; McAllister SS
    Breast Cancer Res; 2017 Mar; 19(1):23. PubMed ID: 28264701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
    Zara S; De Colli M; di Giacomo V; Zizzari VL; Di Nisio C; Di Tore U; Salini V; Gallorini M; Tetè S; Cataldi A
    Clin Oral Investig; 2015 Apr; 19(3):601-11. PubMed ID: 25055744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroblast growth factor 2 supports osteoblastic niche cells during hematopoietic homeostasis recovery after bone marrow suppression.
    Yoon KA; Son Y; Choi YJ; Kim JH; Cho JY
    Cell Commun Signal; 2017 Jun; 15(1):25. PubMed ID: 28662672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteoclast activity modulates B-cell development in the bone marrow.
    Mansour A; Anginot A; Mancini SJ; Schiff C; Carle GF; Wakkach A; Blin-Wakkach C
    Cell Res; 2011 Jul; 21(7):1102-15. PubMed ID: 21321604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drugs which inhibit osteoclast function suppress tumor growth through calcium reduction in bone.
    Li X; Liao J; Park SI; Koh AJ; Sadler WD; Pienta KJ; Rosol TJ; McCauley LK
    Bone; 2011 Jun; 48(6):1354-61. PubMed ID: 21419883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential impact of Ink4a and Arf on hematopoietic stem cells and their bone marrow microenvironment in Bmi1-deficient mice.
    Oguro H; Iwama A; Morita Y; Kamijo T; van Lohuizen M; Nakauchi H
    J Exp Med; 2006 Oct; 203(10):2247-53. PubMed ID: 16954369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bmi1 Suppresses Adipogenesis in the Hematopoietic Stem Cell Niche.
    Hu T; Kitano A; Luu V; Dawson B; Hoegenauer KA; Lee BH; Nakada D
    Stem Cell Reports; 2019 Sep; 13(3):545-558. PubMed ID: 31257132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Megakaryocytes promote murine osteoblastic HSC niche expansion and stem cell engraftment after radioablative conditioning.
    Olson TS; Caselli A; Otsuru S; Hofmann TJ; Williams R; Paolucci P; Dominici M; Horwitz EM
    Blood; 2013 Jun; 121(26):5238-49. PubMed ID: 23667055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of osteoclast function reduces hematopoietic stem cell numbers in vivo.
    Lymperi S; Ersek A; Ferraro F; Dazzi F; Horwood NJ
    Blood; 2011 Feb; 117(5):1540-9. PubMed ID: 21131587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche.
    Méndez-Ferrer S; Michurina TV; Ferraro F; Mazloom AR; Macarthur BD; Lira SA; Scadden DT; Ma'ayan A; Enikolopov GN; Frenette PS
    Nature; 2010 Aug; 466(7308):829-34. PubMed ID: 20703299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin enhances long-term hematopoietic reconstitution of ex vivo expanded mouse hematopoietic stem cells by inhibiting senescence.
    Luo Y; Li L; Zou P; Wang J; Shao L; Zhou D; Liu L
    Transplantation; 2014 Jan; 97(1):20-9. PubMed ID: 24092377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of zoledronate on the responses of osteocytes to acute parathyroid hormone.
    Kuroshima S; Elliott KW; Yamashita J
    Calcif Tissue Int; 2013 Jun; 92(6):576-85. PubMed ID: 23503790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of zoledronic acid and geranylgeraniol on the cellular behaviour and gene expression of primary human alveolar osteoblasts.
    Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
    Clin Oral Investig; 2016 Nov; 20(8):2023-2035. PubMed ID: 26795621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatial control of bone formation using a porous polymer scaffold co-delivering anabolic rhBMP-2 and anti-resorptive agents.
    Yu NY; Gdalevitch M; Murphy CM; Mikulec K; Peacock L; Fitzpatrick J; Cantrill LC; Ruys AJ; Cooper-White JJ; Little DG; Schindeler A
    Eur Cell Mater; 2014 Jan; 27():98-109; discussion 109-111. PubMed ID: 24488823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1-mediated osteoblastic niche expansion enhances long-term hematopoietic stem cell engraftment after murine bone marrow transplantation.
    Caselli A; Olson TS; Otsuru S; Chen X; Hofmann TJ; Nah HD; Grisendi G; Paolucci P; Dominici M; Horwitz EM
    Stem Cells; 2013 Oct; 31(10):2193-204. PubMed ID: 23818291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice.
    Orlandi A; Chavakis E; Seeger F; Tjwa M; Zeiher AM; Dimmeler S
    Basic Res Cardiol; 2010 Nov; 105(6):703-12. PubMed ID: 20652278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone and Stem Cells. Regulation of hematopoietic microenvironment by bone metabolism].
    Katayama Y
    Clin Calcium; 2014 Apr; 24(4):547-54. PubMed ID: 24681501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent inhibitory effects of zoledronic acid on osteoblast viability and function in vitro.
    Huang X; Huang S; Guo F; Xu F; Cheng P; Ye Y; Dong Y; Xiang W; Chen A
    Mol Med Rep; 2016 Jan; 13(1):613-22. PubMed ID: 26648136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.